Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 12 - Number 2
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
, 12(2): 85 - 96L. A. Stivala, O. Cazzalini and E. Prosperi
DOI: 10.2174/156800912799095126
Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung Carcinoma
, 12(2): 97 - 106H. A.N. Al-Wadei, M. H. Al-Wadei, M. F. Ullah and H. M. Schuller
DOI: 10.2174/156800912799095171
Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
, 12(2): 107 - 123S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge
DOI: 10.2174/156800912799095144
Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy
, 12(2): 124 - 131P. Cejas, M. Lopez-Gomez, C. Aguayo, R. Madero, J. Moreno-Rubio, J. de Castro Carpeno, C. Belda-Iniesta, J. Barriuso, V. Moreno Garcia, E. Diaz, E. Burgos, M. Gonzalez-Baron and J. Feliu
DOI: 10.2174/156800912799095162
Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal Adenocarcinoma
, 12(2): 132 - 143E. Piazuelo, S. Santander, C. Cebrian, P. Jimenez, C. Pastor, M. A. Garcia-Gonzalez, F. Esteva, P. Esquivias, J. Ortego and A. Lanas
DOI: 10.2174/156800912799095199
Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer
, 12(2): 144 - 163V. Jeet, P. J. Russell, N. D. Verma and A. Khatri
DOI: 10.2174/156800912799095180
Transplacental Antioxidants Inhibit Lung Tumors in Mice Exposed to Cigarette Smoke After Birth: A Novel Preventative Strategy?
, 12(2): 164 - 169R. Balansky, G. Ganchev, M. Iltcheva, V. E. Steele and S. De Flora
DOI: 10.2174/156800912799095153
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
, 12(2): 170 - 184S. Tan, E. G.E. de Vries, A. G.J. van der Zee and S. de Jong
DOI: 10.2174/156800912799095135
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net